Here we analyzed data from the NCI-60 database (https://dtp.cancer.gov/discovery_development/nci-60/) to identify compounds that preferentially target human tumor cells carrying nonsense mutant TP53. We identified 5-Fluorouracil (5-FU) as a potential readthrough-inducing agent. This evidence concerns the gene TP53 and neoplasm.